JP2016527900A - cMET核酸のマルチモード解析のための組成物および方法 - Google Patents

cMET核酸のマルチモード解析のための組成物および方法 Download PDF

Info

Publication number
JP2016527900A
JP2016527900A JP2016534613A JP2016534613A JP2016527900A JP 2016527900 A JP2016527900 A JP 2016527900A JP 2016534613 A JP2016534613 A JP 2016534613A JP 2016534613 A JP2016534613 A JP 2016534613A JP 2016527900 A JP2016527900 A JP 2016527900A
Authority
JP
Japan
Prior art keywords
primer
cmet
gene
level
primers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016534613A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016527900A5 (enExample
Inventor
ヨルク ノリング
ヨルク ノリング
キラン マダナハリー ディバカル
キラン マダナハリー ディバカル
Original Assignee
キアゲン マンスフィールド インコーポレイテッド
キアゲン マンスフィールド インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by キアゲン マンスフィールド インコーポレイテッド, キアゲン マンスフィールド インコーポレイテッド filed Critical キアゲン マンスフィールド インコーポレイテッド
Publication of JP2016527900A publication Critical patent/JP2016527900A/ja
Publication of JP2016527900A5 publication Critical patent/JP2016527900A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2527/00Reactions demanding special reaction conditions
    • C12Q2527/143Concentration of primer or probe
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2016534613A 2013-08-14 2014-08-07 cMET核酸のマルチモード解析のための組成物および方法 Pending JP2016527900A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361865755P 2013-08-14 2013-08-14
US61/865,755 2013-08-14
PCT/US2014/050076 WO2015023503A2 (en) 2013-08-14 2014-08-07 Compositions and methods for multimodal analysis of cmet nucleic acids

Publications (2)

Publication Number Publication Date
JP2016527900A true JP2016527900A (ja) 2016-09-15
JP2016527900A5 JP2016527900A5 (enExample) 2017-06-22

Family

ID=51358135

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016534613A Pending JP2016527900A (ja) 2013-08-14 2014-08-07 cMET核酸のマルチモード解析のための組成物および方法

Country Status (9)

Country Link
US (1) US20160130660A1 (enExample)
EP (1) EP3033434A2 (enExample)
JP (1) JP2016527900A (enExample)
KR (1) KR20160106040A (enExample)
CN (1) CN105745335A (enExample)
BR (1) BR112016003057A2 (enExample)
CA (1) CA2917924A1 (enExample)
SG (1) SG11201600754PA (enExample)
WO (1) WO2015023503A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114717264A (zh) 2014-11-14 2022-07-08 沃雅戈治疗公司 治疗肌萎缩性侧索硬化(als)的组合物和方法
WO2018025856A1 (ja) * 2016-08-02 2018-02-08 学校法人武庫川学院 簡便な遺伝子検査法およびコピー数計測法ならびにその支援技術
WO2018204786A1 (en) 2017-05-05 2018-11-08 Voyager Therapeutics, Inc. Compositions and methods of treating amyotrophic lateral sclerosis (als)
US11434502B2 (en) 2017-10-16 2022-09-06 Voyager Therapeutics, Inc. Treatment of amyotrophic lateral sclerosis (ALS)
CN108893536B (zh) * 2018-07-13 2022-02-15 江苏省人民医院(南京医科大学第一附属医院) 一种从人外周血CTC中检测c-MET基因拷贝数变异的方法和试剂盒
US20210324461A1 (en) * 2018-08-16 2021-10-21 Life Technologies Corporation Reagents, mixtures, kits and methods for amplification of nucleic acids
KR20210107492A (ko) * 2020-02-24 2021-09-01 (재)록원바이오융합연구재단 복제수 변이 검출용 표준화 유전자의 선별 방법 및 상기 방법에 의해서 선별된 c-Met 복제수 변이 검출용 조성물

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3756313B2 (ja) 1997-03-07 2006-03-15 武 今西 新規ビシクロヌクレオシド及びオリゴヌクレオチド類縁体
US7445893B2 (en) 2002-04-12 2008-11-04 Primera Biosystems, Inc. Sampling method for amplification reaction analysis
US20070213292A1 (en) 2005-08-10 2007-09-13 The Rockefeller University Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof
CA2705146A1 (en) 2007-11-07 2009-05-14 Primeradx, Inc. Quantification of nucleic acid molecules using multiplex pcr
EP2143441A1 (en) * 2008-07-08 2010-01-13 Pierre Fabre Medicament Combination of a c-Met antagonist and an aminoheteroaryl compound for the treatment of cancer
PA8849001A1 (es) * 2008-11-21 2010-06-28 Lilly Co Eli Anticuerpos de c-met
US9689028B2 (en) * 2008-12-22 2017-06-27 University Of Utah Foundation Monochrome multiplex quantitative PCR
MX2013007429A (es) * 2010-12-23 2014-01-31 Nestec Sa Seleccion de farmacos para terapia de cancer maligno usando disposiciones a base de anticuerpos.
ES2734673T3 (es) * 2011-03-02 2019-12-11 Nestle Sa Predicción de la sensibilidad farmacológica de tumores de pulmón basándose en identificaciones moleculares y genéticas

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BIOTECHNIQUES, 2012, VOL.52, NO.5, P.316-324, JPN6018017228, ISSN: 0003794454 *
GOETSCH L: "SELECTION CRITERIA FOR C-MET-TARGETED THERAPIES: EMERGING EVIDENCE FOR BIOMARKERS", BIOMARKERS IN MEDICINE, vol. VOL:4, NR:1, JPN5016009087, February 2010 (2010-02-01), GB, pages 149 - 170, ISSN: 0003930303 *
PRIMERADX, "CMET: SIMULTANEOUS AND QUANTITATIVE ANALYSIS OF COPY NUMBER VARIATION AND GENE EXPRESSIO, JPN6018017224, ISSN: 0003930301 *
PRIMERADX, "CMET: SIMULTANEOUS AND QUANTITATIVE ANALYSIS OF COPY NUMBER VARIATION AND GENE EXPRESSIO, JPN6018017226, ISSN: 0003930302 *

Also Published As

Publication number Publication date
US20160130660A1 (en) 2016-05-12
BR112016003057A2 (pt) 2017-11-21
CA2917924A1 (en) 2015-02-19
SG11201600754PA (en) 2016-02-26
KR20160106040A (ko) 2016-09-09
EP3033434A2 (en) 2016-06-22
WO2015023503A2 (en) 2015-02-19
WO2015023503A3 (en) 2015-07-16
CN105745335A (zh) 2016-07-06

Similar Documents

Publication Publication Date Title
US9909179B2 (en) Single-cell nucleic acid analysis
JP2016527900A (ja) cMET核酸のマルチモード解析のための組成物および方法
CN108342453A (zh) 基于探针的核酸检测
JP5932808B2 (ja) 標的核酸の検出方法
CN106574303A (zh) 用于结肠直肠癌的甲基化的标志物
US20150011416A1 (en) Multimodal pcr target detection
JP6007652B2 (ja) メチシリン耐性黄色ブドウ球菌を検出するためのプライマーおよびプローブ、ならびに、それらを用いたメチシリン耐性黄色ブドウ球菌の検出方法
US20160108479A1 (en) Compositions and methods for multiplex analysis of nras and braf nucleic acids
WO2016172126A2 (en) Experimentally validated sets of gene specific primers for use in multiplex applications
EP3055430B1 (en) Method for the detection of target nucleic acid sequences
WO2018101375A1 (ja) ヒトゲノムdna検出方法
WO2005075680A1 (ja) 核酸検出方法およびその利用
JP2014180278A (ja) 核酸の解析方法、そこにおいて使用されるアッセイキット
JP2010525837A (ja) アスペルギルス(Aspergillus)におけるトリアゾール耐性の検出
HK1227444A1 (en) Method for the detection of target nucleic acid sequences
HK1227444B (en) Method for the detection of target nucleic acid sequences

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160420

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170509

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170509

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180514

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20181203